Last reviewed · How we verify
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
This research is being done to see if an investigational radioactive imaging agent (radiotracer) called 18F-DCFPyL can help us find prostate cancer at its original site in the prostate gland and in distant sites (bone, lymph nodes) in men diagnosed with prostate cancer before surgery.
Details
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | COMPLETED |
| Enrolment | 23 |
| Start date | Thu Dec 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Mar 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Advanced Prostate Cancer
Interventions
- Pelvic DCFPyL PET-MRI fusion or PET/MRI
Countries
United States